Cysto-Conray II 172 mg/mL (Iothalamate meglumine INJECTION) 172 mg/mL

Cysto-Conray II 172 mg/mL is a diagnostic imaging agent used for visualizing the urinary tract. This injection contains iothalamate meglumine and is designed for ureteral administration. It is commonly used in medical procedures to aid in the diagnosis of urinary tract conditions.

Strength

172 mg/mL

Pack Size

12 BOTTLE, GLASS in 1 BOX (0019-0862-50) / 250 mL in 1 BOTTLE, GLASS

Manufacturer / TM Owner

Liebel-Flarsheim Company LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cysto-Conray II 172 mg/mL is primarily used for diagnostic imaging of the urinary tract. It helps in visualizing the kidneys, ureters, and bladder, which can be crucial for identifying blockages, abnormalities, or other conditions. This injection is often administered during procedures to provide clear images for medical evaluation.

Side Effects

The effects of Cysto-Conray II 172 mg/mL are typically observed during diagnostic imaging procedures. It helps to enhance the visibility of the urinary tract structures, allowing healthcare professionals to assess their condition. Common effects may include temporary discomfort or warmth at the injection site.

Precautions & Warnings

Cysto-Conray II 172 mg/mL should be handled with care and administered by healthcare professionals. It is important to follow proper procedures to ensure safety and effectiveness. Patients should inform their healthcare provider about any allergies or medical conditions before administration.

Avoid Interactions

Cysto-Conray II 172 mg/mL may interact with certain medications or substances. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect the body's response to this diagnostic agent.

Frequently Asked Questions

Cysto-Conray II 172 mg/mL is used for diagnostic imaging of the urinary tract, helping to visualize structures like the kidneys, ureters, and bladder.

Cysto-Conray II 172 mg/mL is administered via injection into the ureteral region, typically by a healthcare professional during a diagnostic procedure.

Common effects may include temporary discomfort or warmth at the injection site, as the agent helps to enhance the visibility of urinary tract structures.

Yes, it should be handled with care and administered by healthcare professionals. Patients should inform their provider about any allergies or medical conditions.

It may interact with certain medications or substances, so it is important to discuss all current medications with a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.